Latest Market Updates
Regulations
Last Updated: 30 July 2026
Technical definition of FDA 510k clearance
The US FDA Medical Device Registration process is highly complex; however, as regulatory experts, Morulaa supports you by developing compliant registration dossiers tailored to current regulatory standards.The regulatory process establishes the FDA 510k clearance process. This process entails demonstration of Substantial Equivalence (SE). Substantial equivalence takes place in comparison between a new medical device or In Vitro Diagnostic (IVD) and a predicate legally in the market. The premarket approval (PMA) process also involves conducting independent clinical trials. The 510k process entirely relies on data of comparative performance.
The SE will be confirmed if the device:
Has the same intended use as the predicate.
Has similar technological characteristics.
Is different in characteristics without posing any new questions on safety and effectiveness.
510k submission Data Integrity and RTA Criteria
Every 510k application undergoes "Refuse to Accept" FDA RTA screening as a first step of the regulatory review process. This administrative procedure takes no more than 15 calendar days. An RTA determination can be made due to lack of proper data technical documentation files. The clock for the formal substantive review starts only after the RTA letter is issued which is then accepted by FDA.
The following data points are mandatory for the FDA clearance:
Technical Performance Testing: Bench testing protocols, biocompatibility, and software validation code
Comparative Analysis: Tabular overview of technical specifications
Risk Management Assessment: ISO 14971 harmonized hazard analysis
An FDA 510k expert can assist in aligning the submission with the quality of documentation required by the reviewing authorities to avoid RTA issues.
The Role of the FDA 510k Clearance consultant in Strategic Alignment
An FDA 510k consultant maps out the regulatory process through calculation of equivalence indicators. The process requires precise technical equivalence. Digital health products are expected to be reviewed within $90$ days. Any failure or mismatch of results while testing may extend or even lack quality of data can take a longer period of regulatory process than usual . Claims which are made based on theory or which lack proper analytical data will not be entertained. While claims with mathematical proof are essential for consideration.
Adverse Event Reporting and Post Market Compliance under FDA
Following your US FDA Medical Device Registration Process, Morulaa will support you in FDA Incident Reporting. Market launch starts the post clearance surveillance. Databases to monitor adverse events and report them to FDA are created by manufacturers. This also helps the manufacturers to monitor the performance of devices in actual clinical settings.
Operational requirements
Compliance with 21 CFR Part 803 for Medical Device Reporting (MDR)
Implementation of 21 CFR Part 820 for Quality System Regulation (QSR)
Yearly verification of US FDA medical device registration
Technical experts make sure that there is a transition from pre market design files to post market surveillance. In this context, the FDA adverse event reporting helps maintain legal compliance.
Device Classification and 510k submission Process
The FDA determines the class of a device according to its risk from low to high, which are classes I, II, and III, respectively. A 510k application is intended for Class II hardware and In Vitro Diagnostic (IVD) medical devices regulated by FDA 21 CFR Part 809. Tests are conducted to monitor the practical performance of hardware and the analysis of data is used to obtain IVD FDA 510k clearance. The latter encompasses the information on the accuracy of analytical procedures, including detection capability and quantitative analysis.
Furthermore, Substantial Equivalence (SE) is the standard for any medical device, meaning that new technology should undergo isolated testing in order to prove that it does not interfere with established safety processes. At the same time, the lack of a predicate device results in a De Novo or PMA pathway.
Technical variants of FDA 510k clearance
When your application is submitted to FDA it is sorted by them into three categories based on technical criteria, the classifications are as follows:
Traditional: The process that is used when the device has a valid predicate. The time it takes to approve a traditional application is about 90 days.
Special: The procedure applies to a device that is internally modified, where the intended uses of the product remain the same. The manufacturer’s previous device serves as the predicate.
Abbreviated: The application refers to a device that is compared to FDA’s guidance files or consensus standards to demonstrate SE.
Strategic Methodology of 510k submission consultants
510k submission consultants follow an established set of steps before uploading any data.
Predicate Selection: is searching for a similar device already on the market with comparable risk class and documented outputs
Gap Analysis: will compare the raw bench data to the relevant ISO 10993 and IEC standards
Pre Submission, or Q sub: is a direct communication with the FDA to agree on the details of testing, which decreases the risk of RTA (Refusal to Accept) significantly
Finally, prior to any electronic submissions, consultants will make sure that all data is secured and locked.
Accelerating FDA 510k Clearance through eSTAR and Digital Compliance
It is not a practical norm of a consultant to upload scanned copies unless the information in it is validated. Finally, to speed up the process, eSTAR and digital compliance technologies allow for automatically filling out a PDF copy of the RTA checklist. eSTAR application requires consultation because the software will need to collect all the necessary data on its own to fill in the fields for software validation and labeling.
The Cybersecurity part of data used especially for network related devices is regulated by the PATCH Act. It includes a list of software components (SBOM), procedures for post market vulnerability management, and a predetermined change control plan (PCCP) for the modification of algorithms in artificial intelligence (AI)/machine learning (ML). Such an approach eliminates the need to resubmit new versions of the 510k.
FDA medical device reports and compliance
Authorization for market placement comes under FDA medical device reporting (MDR) regulations, codified under 21 CFR Part 803 of the FDA’s regulations. In other words, the FDA requires companies to report to it any incidents that involve the malfunction of a device or the injury of a patient under the jurisdiction of the agency. The specific details of such incidents are regulated by the Quality Management System (QMS) and must be submitted according to the procedures established by the system.
Costs for Submission and Establishment Registration
In Fiscal Year 2026, it is required to comply with the Medical Device User Fee Amendments schedule.
Technical Review Time for FDA 510k Clearance
The eSTAR portal does have a time period it is responsible for which includes:.
eSTAR submission (PDF): electronic application data transfer
Acceptance Review (day 15): RTA system check
Substantive Review (day 60): bench and clinical data examination
Supplemental Information (AI) Request: Review Clock Is Stopped. The maximum response time allowed is 180 days.
Final Decision (day 90): SE’s determination for FDA 510k clearance
Post Market Compliance: QMSR and FDA Adverse Event Reporting
21 CFR part 820 Quality System Regulation (QSR): The standard ISO 13485:2016 alignment coordination United States and international data needs.
FDA adverse event reporting for Class II, III medical devices:
Design controls over product specification and verification documents
Risk management (ISO 14971)
Management responsibility (management audits and their control effectiveness)
Critical malfunction makes manufacturers follow FDA’s adverse event report regulations
Strategic Data Requirements for Implementing US FDA Medical Device Registration
Data accuracy prevents an application from being declined due to administrative errors. Morulaa Health Tech audit particular aspects of a submission:
Proper classification: product code assignment
Gap analysis: IEC, ISO, and AAMI standards conformity
Performance data extraction: LoD (Limit of Detection) and analytical sensitivity for In Vitro Diagnostic devices (IVDs)
Post Clearance Maintenance: MDUFA fees and establishment registration.
Frequently Asked Questions
Who must complete FDA Establishment Registration?
21 CFR part 807 prescribes that both domestic and foreign facilities must register with FDA. This includes medical device manufacturing, re packaging or labeling for sale in the US, or initial importation of devices. Additionally, it includes sterilization facilities who are directly involved in the process of creating medical devices. FDA establishment registration is used to develop an inventory of suppliers for the Food and Drug Administration.
What is the time for the FDA 510k clearance review process?
A legal review is conducted continuously and takes approximately 90 days. The Food and Drug Administration sends out Additional Information (AI) requests for any missing technical information. An AI request stops the FDA clock for 90 days. The manufacturer then has to supply the needed parameters within $\le 180$ days. An FDA 510k expert reviews the eSTAR templates to avoid these specific delays from occurring.
Do Class I devices require full QMSR compliance?
21CFR Part 820 Quality System Regulation (QSR) stipulates that Class I medical devices with reduced risk require exemption from the design control requirements of the FDA’s Quality System Regulation. On the contrary, Class II and Class III medical devices require full QSR compliance, including design control documentation throughout the audit trail of the manufacturing processes. Consequently, the QMSR consultant will ensure full compliance with the Quality System Regulation for the higher risk medical devices.
How is compliance maintained after the market?
Compliance maintenance entails establishing procedures that enable the continual fulfillment of applicable requirements and meeting all quality standards while monitoring and reviewing the procedures to ensure their effectiveness constantly. 21CFR Part 803 covers FDA medical device reporting regulations, requiring manufacturers to report to the FDA whenever a medical device undergoes a serious malfunction or adversely affects the health of the consumers. The 510k submission consultants, Morulaa Health Tech configures Quality Management System (QMS) tracking logs in relation to the requirements specified in this part to monitor reports on serious incidents affecting the consumers of the medical devices.